Hartleys have just initiated coverage of EGO with a Speculative Buy recommendation and a 0.75 cent price target. Hopefully this report will get a bit of attention
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%